Novo Nordisk A/S ADR (NVO)
70.42 x 100 70.55 x 100
Post-market by (Cboe BZX)
70.16 -1.57 (-2.19%) 03/27/25 [NYSE]
70.42 x 100 70.55 x 100
Post-market 70.43 +0.27 (+0.38%) 19:53 ET
for Thu, Mar 27th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,643,260 | 12,150,770 | 7,862,340 | 7,598,139 | 6,455,542 |
| Depreciation Amortization | 2,770,515 | 1,366,768 | 1,042,459 | 958,578 | 881,360 |
| Accounts receivable | -1,040,955 | -2,063,292 | -1,404,247 | -2,053,822 | -432,330 |
| Accounts payable and accrued liabilities | 469,800 | 1,454,759 | 951,127 | 501,642 | -98,201 |
| Other Working Capital | 1,492,340 | 2,903,710 | -755,578 | -1,377,170 | -666,880 |
| Other Operating Activity | -794,600 | 725 | 3,474,298 | 3,123,133 | 1,819,403 |
| Operating Cash Flow | $17,540,360 | $15,813,440 | $11,170,400 | $8,750,500 | $7,958,893 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 777,635 | -690,862 | -413,614 | 186,465 | N/A |
| PPE Investments | -6,838,780 | -3,747,031 | -1,719,874 | -1,007,898 | -891,318 |
| Net Acquisitions | -11,913,630 | N/A | -1,001,820 | -2,908,825 | N/A |
| Purchase Of Investment | -113,970 | -39,349 | -23,930 | -1,131,678 | -60,054 |
| Sale Of Investment | N/A | 4,792 | N/A | N/A | 1,838 |
| Purchase Sale Intangibles | -601,025 | -1,900,668 | -369,151 | -167,055 | -2,490,419 |
| Other Investing Activity | -601,035 | -1,900,668 | -369,151 | -166,419 | -2,487,661 |
| Investing Cash Flow | $-18,689,780 | $-6,373,118 | $-3,528,389 | $-5,028,355 | $-3,437,195 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11,511,700 | N/A | 1,588,044 | 3,525,656 | 870,482 |
| Debt Repayment | -918,575 | -213,008 | -1,929,017 | -1,064,220 | -145,540 |
| Common Stock Repurchased | -2,926,245 | -4,344,965 | -3,410,578 | -3,094,018 | -2,582,186 |
| Dividend Paid | -6,400,300 | -4,612,568 | -3,582,905 | -3,423,355 | -3,082,537 |
| Other Financing Activity | -5 | -1 | 1 | 1 | 0 |
| Financing Cash Flow | $1,266,575 | $-9,170,542 | $-7,334,455 | $-4,055,936 | $-4,939,781 |
| Exchange Rate Effect | 65,975 | -17,279 | -33,701 | 94,028 | -69,859 |
| Beginning Cash Position | 2,086,840 | 1,837,216 | 1,517,810 | 1,945,157 | 2,360,965 |
| End Cash Position | 2,269,975 | 2,089,719 | 1,791,665 | 1,705,393 | 1,873,023 |
| Net Cash Flow | $183,135 | $252,503 | $273,854 | $-239,764 | $-487,942 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,540,360 | 15,813,440 | 11,170,400 | 8,750,500 | 7,958,893 |
| Capital Expenditure | -6,838,780 | -3,747,031 | -1,719,874 | -1,007,898 | -892,390 |
| Free Cash Flow | 10,701,580 | 12,066,409 | 9,450,526 | 7,742,602 | 7,066,503 |